Italian researchers have altered the atomic makeup of aspirin to make it less harsh on users' stomach linings, experts said.
Scientists from Turin and Parma Universities added atoms onto the aspirin's main molecule, preventing the common headache drug from destroying the lining of the stomach, head researcher Alberto Gasco said.
Aspirin's destructive impact on stomach tissue has been found to cause ulcers and irritation in its users because of the way it is absorbed into the bloodstream, ANSA reported Monday.
The new form medicine "has no side effects," Gasco said in the Journal of Medicinal Chemistry.
The new aspirin has only gone through trials involving rats, Gasco said.
''But if the results are confirmed by further tests, it should represent a safer alternative to old aspirin in very many clinical applications''.
Copyright 2008 by United Press International
Related stories:
New aspirin-like substances may provide safer way to fight heart disease
Researchers in Italy report development of a new group of aspirin-like substances that may be safer and as effective as conventional aspirin for fighting heart disease, the leading cause of death in the developed world. Their study is scheduled for the March 27 issue of the ACS’
Journal of Medicinal Chemistry.
A new century of Alzheimer's disease research
Imagine the day when a routine visit to the family doctor includes a simple blood test to predict the risk for developing Alzheimer’s disease (AD). If the test returns a worrisome result -- too many sticky brain proteins that might begin to gum up memory and thought in 10 to 15 years -- a person could be offered an aspirin-like pill to keep those proteins in check.
St. Jude finds 'dancing' hair cells are key to humans' acute hearing
St. Jude Children's Research Hospital investigators have found that an electrically powered amplification mechanism in the cochlea of the ear is critical to the acute hearing of humans and other mammals. The findings will enable better understanding of how hearing loss can result from malfunction of this amplification machinery due to genetic mutation or overdose of drugs such as aspirin.
Daily aspirin may reduce risk of common type of breast cancer
Taking aspirin on a daily basis may lower women’s risk of a particular type of breast cancer, according to results published in BioMed Central’s open access journal
Breast Cancer Research. In this large study, aspirin use was linked to a small reduction in estrogen receptor-positive breast cancers. However, unlike in some previous research, aspirin and related painkillers were not found to reduce the total risk of breast cancer.
FDA seeks more information from Merck for cholesterol drug
(AP) -- A Merck & Co. experimental drug has been rejected by the U.S. Food and Drug Administration for the second time in four days.
Aspirin-like compounds increase insulin secretion in otherwise healthy obese people
Aspirin-like compounds (salicylates) can claim another health benefit: increasing the amount of insulin produced by otherwise healthy obese people. Obesity is associated with insulin resistance, the first step toward type 2 diabetes.
New molecule could be key to anti-heart attack drug
When too many blood platelets stick together in the bloodstream, they form dangerous clots that can clog blood vessels and cause a heart attack. If a clot doesn’t get dissolved or rapidly removed, it can cause permanent damage or even death. But new research by Rockefeller University scientists suggests that it should be possible to create a clot-busting pill that targets a receptor on the blood cells’ surface, something that high-risk patients could take at the first sign of chest pain.
Creatinine increase in elderly means increased renal disease, mortality
Even small increases in serum creatinine levels during hospitalization raise the risk of end stage renal disease and mortality of elderly patients over the long term, according to a University of Alabama at Birmingham (UAB) study in the
Archives of Internal Medicine.